Research

Our agency supports research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases through funding, evaluation, research coordination and scientific facilitation.

Last updated on 06 March 2025

Diseases and pathogens

  • HIV/AIDS: The human immunodeficiency virus (HIV) remains a major priority for ANRS MIE. The agency supports multidisciplinary research aimed at improving prevention, screening, treatment and cure for people living with HIV. Funding is also provided for projects exploring the interactions between HIV and other infections or pathologies, in order to better understand and combat this complex disease.
  • Viral hepatitis: Hepatitis B, C and D represent a global public health issue. The ANRS MIE funds and coordinates research aimed at improving our understanding of these infections, developing new treatments and optimising prevention and screening strategies. The agency also supports epidemiological studies to better understand the impact of these diseases in different populations.
  • Sexually Transmitted Infections (STIs):ANRS MIE is involved in the fight against other STIs, such as syphilis, gonorrhoea and chlamydia. Funding is provided for research projects aimed at improving the screening, treatment and prevention of these infections, taking into account risk behaviour and the social determinants of health.
  • Tuberculosis: Despite medical advances, tuberculosis remains one of the most deadly infectious diseases. The ANRS MIE supports research aimed at gaining a better understanding of the transmission of Mycobacterium tuberculosis, developing more effective treatments and improving prevention strategies. The agency also encourages ‘One Health’ approaches to study the links between human and animal tuberculosis.
  • Emerging infectious diseases: Faced with the emergence of new health threats, such as Covid-19, viral haemorrhagic fevers and arboviroses, ANRS MIE is mobilising to fund and coordinate research aimed at understanding these pathogens, developing diagnostic tools, treatments and vaccines, and strengthening health crisis response capacities. The agency adopts an integrated approach, looking at human, animal and environmental health, in line with the ‘One Health’ concept.

Discover the latest news on pathogens



Mpox

Mpox (formerly known as monkeypox) is a disease that has been circulating for decades in West and Central Africa.

Oropouche

Oropouche virus disease is an arboviral disease actively circulating in several regions of Central and South America and the Caribbean.

Avian influenza A (H5N1)

Avian influenza, also known as bird flu or formerly fowl plague, caused by A strains of the influenza virus, is an infectious disease affecting wild and domestic birds.

Research projects

Here are a few examples of the research projects we fund. More information about our clinical research projects involving the storage of samples hosted in our biobank can be found in Data and samples.

183
new research projects funded and/or sponsored by our agency in 2023

*This section does not include an exhaustive list of the research projects supported by ANRS MIE.

Scientific animation groups

The agency brings people together within a variety of groups, such as coordinated actions (CA), workgroups and sub-groups, networks, and task forces.

For more information

Scientific commitments

ANRS Emerging Infectious Diseases is committed to structuring its activities for the benefit of research and the scientific community.



Open science

Open science refers to the unhindered dissemination of results, methods and products from scientific research.